Cardiovascular Risk Assessment in Patients Treated With Caduet (RIGHT)

January 26, 2021 updated by: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Cardiovascular Risk Assessment In Patients With Hypertension And At Least Three Other Risk Factors, Treated With Caduet Compared To Usual Care: The Right Study

Compare the reduction in Framingham's predicted 10-year risk of a coronary event (6) in patients with hypertension and at least three other cardiovascular risk factors (including diabetic patients) seen in private practice and randomized to either Caduet or usual care.

Study Overview

Status

Completed

Conditions

Hypertension

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

1442

Phase

Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

France
- - Abbeville, France, 80100
    - Pfizer Investigational Site
  - Aire Sur La Lys, France, 62120
    - Pfizer Investigational Site
  - Aix Les Bains, France, 73100
    - Pfizer Investigational Site
  - Alencon, France, 61000
    - Pfizer Investigational Site
  - Allaire, France, 56350
    - Pfizer Investigational Site
  - Amboise, France, 37400
    - Pfizer Investigational Site
  - Amiens, France, 80000
    - Pfizer Investigational Site
  - Amiens, France, 80080
    - Pfizer Investigational Site
  - Amiens Cedex 3, France, 80094
    - Pfizer Investigational Site
  - Andrezieux Boutheon, France, 42160
    - Pfizer Investigational Site
  - Angers, France, 49000
    - Pfizer Investigational Site
  - Annecy, France, 74000
    - Pfizer Investigational Site
  - Annecy Le Vieux, France, 74940
    - Pfizer Investigational Site
  - Annemasse, France, 74100
    - Pfizer Investigational Site
  - Anzin, France, 59410
    - Pfizer Investigational Site
  - Appoigny, France, 89380
    - Pfizer Investigational Site
  - Apt, France, 84400
    - Pfizer Investigational Site
  - Argenteuil, France, 95100
    - Pfizer Investigational Site
  - Arles, France, 13200
    - Pfizer Investigational Site
  - Arneke, France, 59285
    - Pfizer Investigational Site
  - Arpajon, France, 91290
    - Pfizer Investigational Site
  - Arsac, France, 33460
    - Pfizer Investigational Site
  - Aubagne, France, 13400
    - Pfizer Investigational Site
  - Auchel, France, 62260
    - Pfizer Investigational Site
  - Audresselles, France, 62164
    - Pfizer Investigational Site
  - Autrans, France, 38880
    - Pfizer Investigational Site
  - Balma, France, 31130
    - Pfizer Investigational Site
  - Bastia, France, 20200
    - Pfizer Investigational Site
  - Bayonne, France, 64100
    - Pfizer Investigational Site
  - Beaucaire, France, 30300
    - Pfizer Investigational Site
  - Beaumont Les Valence, France, 26760
    - Pfizer Investigational Site
  - Beaurains, France, 62217
    - Pfizer Investigational Site
  - Beausoleil, France, 06240
    - Pfizer Investigational Site
  - Belley, France, 01300
    - Pfizer Investigational Site
  - Belpech, France, 11420
    - Pfizer Investigational Site
  - Benquet, France, 40280
    - Pfizer Investigational Site
  - Berck, France, 62600
    - Pfizer Investigational Site
  - Bersee, France, 59235
    - Pfizer Investigational Site
  - Bethune, France, 62400
    - Pfizer Investigational Site
  - Beziers, France, 34500
    - Pfizer Investigational Site
  - Biarritz, France, 64200
    - Pfizer Investigational Site
  - Blasimon, France, 33540
    - Pfizer Investigational Site
  - Blois, France, 41000
    - Pfizer Investigational Site
  - Boen, France, 42130
    - Pfizer Investigational Site
  - Boersch, France, 67530
    - Pfizer Investigational Site
  - Bondues, France, 59910
    - Pfizer Investigational Site
  - Bondy, France, 93140
    - Pfizer Investigational Site
  - Bordeaux, France, 33000
    - Pfizer Investigational Site
  - Bordeaux, France, 33200
    - Pfizer Investigational Site
  - Bourg St. Andeol, France, 07700
    - Pfizer Investigational Site
  - Bourges, France, 18000
    - Pfizer Investigational Site
  - Brehan, France, 56580
    - Pfizer Investigational Site
  - Brest, France, 29200
    - Pfizer Investigational Site
  - Brignoud, France, 38190
    - Pfizer Investigational Site
  - Bruay La Buissiere, France, 62700
    - Pfizer Investigational Site
  - Cabestany, France, 66330
    - Pfizer Investigational Site
  - Caen, France, 14000
    - Pfizer Investigational Site
  - Cagnes Sur Mer, France, 06800
    - Pfizer Investigational Site
  - Cannes, France, 06400
    - Pfizer Investigational Site
  - Cannes La Bocca, France, 06150
    - Pfizer Investigational Site
  - Carnon Plage, France, 34280
    - Pfizer Investigational Site
  - Castelnau Le Fez, France, 34170
    - Pfizer Investigational Site
  - Castelsarrasin, France, 82100
    - Pfizer Investigational Site
  - Castres, France, 81100
    - Pfizer Investigational Site
  - Caylus, France, 82160
    - Pfizer Investigational Site
  - Cergy, France, 95000
    - Pfizer Investigational Site
  - Cestas, France, 33610
    - Pfizer Investigational Site
  - Champagne Au Mont D'Or, France, 69410
    - Pfizer Investigational Site
  - Chanceaux Sur Choisille, France, 37390
    - Pfizer Investigational Site
  - Charleville Mezieres, France, 08000
    - Pfizer Investigational Site
  - Chartres, France, 28000
    - Pfizer Investigational Site
  - Chatou, France, 78400
    - Pfizer Investigational Site
  - Chelles, France, 77500
    - Pfizer Investigational Site
  - Chenove, France, 21300
    - Pfizer Investigational Site
  - Chilly Mazarin, France, 91380
    - Pfizer Investigational Site
  - Clairac, France, 47320
    - Pfizer Investigational Site
  - Clary, France, 59225
    - Pfizer Investigational Site
  - Clermont Ferrand, France, 63100
    - Pfizer Investigational Site
  - Collioure, France, 66190
    - Pfizer Investigational Site
  - Colombier Fontaine, France, 25260
    - Pfizer Investigational Site
  - Colomiers, France, 31770
    - Pfizer Investigational Site
  - Condat Sur Vienne, France, 87920
    - Pfizer Investigational Site
  - Courthezon, France, 84350
    - Pfizer Investigational Site
  - Craponne, France, 69290
    - Pfizer Investigational Site
  - Crecy La Chapelle, France, 77580
    - Pfizer Investigational Site
  - Crest, France, 26400
    - Pfizer Investigational Site
  - Creteil, France, 94000
    - Pfizer Investigational Site
  - Crotenay, France, 39300
    - Pfizer Investigational Site
  - Cuise La Motte, France, 60350
    - Pfizer Investigational Site
  - Denain, France, 59220
    - Pfizer Investigational Site
  - Dijon, France, 21000
    - Pfizer Investigational Site
  - Dugny Sur Meuse, France, 55100
    - Pfizer Investigational Site
  - Dunkerque, France, 59140
    - Pfizer Investigational Site
  - Echirolles, France, 38130
    - Pfizer Investigational Site
  - Eckbolsheim, France, 67201
    - Pfizer Investigational Site
  - Eckwersheim, France, 67550
    - Pfizer Investigational Site
  - Epernay, France, 51200
    - Pfizer Investigational Site
  - Epinal, France, 88000
    - Pfizer Investigational Site
  - Epinay Sur Seine, France, 93800
    - Pfizer Investigational Site
  - Etampes, France, 91150
    - Pfizer Investigational Site
  - Etang Sur Arroux, France, 71190
    - Pfizer Investigational Site
  - Evreux, France, 27000
    - Pfizer Investigational Site
  - Falaise, France, 14700
    - Pfizer Investigational Site
  - Fayence, France, 83440
    - Pfizer Investigational Site
  - Fenioux, France, 79160
    - Pfizer Investigational Site
  - Ferney Voltaire, France, 01210
    - Pfizer Investigational Site
  - Floirac, France, 33270
    - Pfizer Investigational Site
  - Fontaine, France, 38600
    - Pfizer Investigational Site
  - Fontaine Les Dijon, France, 21121
    - Pfizer Investigational Site
  - Fontainebleau, France, 77300
    - Pfizer Investigational Site
  - Fontenay Sous Bois, France, 94120
    - Pfizer Investigational Site
  - Fontes, France, 34320
    - Pfizer Investigational Site
  - Fos Sur Mer, France, 13270
    - Pfizer Investigational Site
  - Franconville, France, 95130
    - Pfizer Investigational Site
  - Fumay, France, 08170
    - Pfizer Investigational Site
  - Gaillefontaine, France, 76870
    - Pfizer Investigational Site
  - Gambsheim, France, 67760
    - Pfizer Investigational Site
  - Gap, France, 05000
    - Pfizer Investigational Site
  - Gonesse, France, 95500
    - Pfizer Investigational Site
  - Gonneville La Mallet, France, 76280
    - Pfizer Investigational Site
  - Gradignan, France, 33170
    - Pfizer Investigational Site
  - Grand Couronne, France, 76530
    - Pfizer Investigational Site
  - Greasque, France, 13850
    - Pfizer Investigational Site
  - Grendelbruch, France, 67190
    - Pfizer Investigational Site
  - Grenoble, France, 38100
    - Pfizer Investigational Site
  - Grenoble, France, 38000
    - Pfizer Investigational Site
  - Groslay, France, 95410
    - Pfizer Investigational Site
  - Guise, France, 02120
    - Pfizer Investigational Site
  - Haguenau, France, 67500
    - Pfizer Investigational Site
  - Harnes, France, 62440
    - Pfizer Investigational Site
  - Hasparren, France, 64240
    - Pfizer Investigational Site
  - Hautmont, France, 59330
    - Pfizer Investigational Site
  - Hochfelden, France, 67270
    - Pfizer Investigational Site
  - Hostens, France, 33125
    - Pfizer Investigational Site
  - Ivry Sur Seine, France, 94200
    - Pfizer Investigational Site
  - Jargeau, France, 45150
    - Pfizer Investigational Site
  - Jarville La Malgrange, France, 54140
    - Pfizer Investigational Site
  - Jeumont, France, 59460
    - Pfizer Investigational Site
  - Jeumont Cedex, France, 59571
    - Pfizer Investigational Site
  - L'Isle Sur La Sorgue, France, 84800
    - Pfizer Investigational Site
  - LA Chapelle Sur Erdre, France, 44240
    - Pfizer Investigational Site
  - LA Rochelle, France, 17000
    - Pfizer Investigational Site
  - La Baule, France, 44500
    - Pfizer Investigational Site
  - La Chapelle Des Marais, France, 44410
    - Pfizer Investigational Site
  - La Ciotat, France, 13600
    - Pfizer Investigational Site
  - La Courneuve, France, 93120
    - Pfizer Investigational Site
  - La Creche, France, 79260
    - Pfizer Investigational Site
  - La Fere, France, 02800
    - Pfizer Investigational Site
  - La Francheville, France, 08000
    - Pfizer Investigational Site
  - La Grande Motte, France, 34280
    - Pfizer Investigational Site
  - La Grande Paroisse, France, 77130
    - Pfizer Investigational Site
  - La Tour Du Crieu, France, 09100
    - Pfizer Investigational Site
  - La Trinite Sur Mer, France, 56470
    - Pfizer Investigational Site
  - Labastidette, France, 31600
    - Pfizer Investigational Site
  - Lacrouzette, France, 81210
    - Pfizer Investigational Site
  - Lamagistere, France, 82360
    - Pfizer Investigational Site
  - Lamarque, France, 33460
    - Pfizer Investigational Site
  - Langon, France, 33210
    - Pfizer Investigational Site
  - Lattes, France, 34970
    - Pfizer Investigational Site
  - Laval, France, 53000
    - Pfizer Investigational Site
  - Lavernose Lacasse, France, 31410
    - Pfizer Investigational Site
  - Laxou, France, 54520
    - Pfizer Investigational Site
  - Le Bourget, France, 93350
    - Pfizer Investigational Site
  - Le Cannet, France, 06110
    - Pfizer Investigational Site
  - Le Havre, France, 76600
    - Pfizer Investigational Site
  - Le Havre, France, 76610
    - Pfizer Investigational Site
  - Le Havre, France, 76620
    - Pfizer Investigational Site
  - Lembeye, France, 64350
    - Pfizer Investigational Site
  - Les Issambres, France, 83380
    - Pfizer Investigational Site
  - Les Sables D'Olonne, France, 85100
    - Pfizer Investigational Site
  - Lesquin, France, 59810
    - Pfizer Investigational Site
  - Liancourt, France, 60140
    - Pfizer Investigational Site
  - Ligny En Barrois, France, 55500
    - Pfizer Investigational Site
  - Lille, France, 59000
    - Pfizer Investigational Site
  - Lille, France, 59800
    - Pfizer Investigational Site
  - Limoges, France, 87000
    - Pfizer Investigational Site
  - Lorient, France, 56100
    - Pfizer Investigational Site
  - Lourdes, France, 65100
    - Pfizer Investigational Site
  - Lucheux, France, 80600
    - Pfizer Investigational Site
  - Luxeuil Les Bains, France, 70300
    - Pfizer Investigational Site
  - Lyon, France, 69009
    - Pfizer Investigational Site
  - Lyon, France, 69008
    - Pfizer Investigational Site
  - Mandelieu La Napoule, France, 06210
    - Pfizer Investigational Site
  - Marcq En Baroeul, France, 59700
    - Pfizer Investigational Site
  - Marseille, France, 13006
    - Pfizer Investigational Site
  - Marseille, France, 13013
    - Pfizer Investigational Site
  - Marseille, France, 13009
    - Pfizer Investigational Site
  - Marseille, France, 13004
    - Pfizer Investigational Site
  - Marseille, France, 13008
    - Pfizer Investigational Site
  - Marseille, France, 13012
    - Pfizer Investigational Site
  - Marseille, France, 13015
    - Pfizer Investigational Site
  - Marseille, France, 13002
    - Pfizer Investigational Site
  - Marseille, France, 13010
    - Pfizer Investigational Site
  - Martigues, France, 13500
    - Pfizer Investigational Site
  - Masseret, France, 19510
    - Pfizer Investigational Site
  - Mauguio, France, 34130
    - Pfizer Investigational Site
  - Meaux Beauval, France, 77100
    - Pfizer Investigational Site
  - Meaux-Beauval, France, 77100
    - Pfizer Investigational Site
  - Mennecy, France, 91540
    - Pfizer Investigational Site
  - Mensignac, France, 24350
    - Pfizer Investigational Site
  - Merlimont, France, 62155
    - Pfizer Investigational Site
  - Metz, France, 57000
    - Pfizer Investigational Site
  - Mirabel Et Blacons, France, 26400
    - Pfizer Investigational Site
  - Miramas, France, 13140
    - Pfizer Investigational Site
  - Miramas Cedex, France, 13141
    - Pfizer Investigational Site
  - Miramont De Guyenne, France, 47800
    - Pfizer Investigational Site
  - Mittersheim, France, 57930
    - Pfizer Investigational Site
  - Mommenheim, France, 67670
    - Pfizer Investigational Site
  - Mons En Baroeul, France, 59370
    - Pfizer Investigational Site
  - Montauroux, France, 83440
    - Pfizer Investigational Site
  - Montbeliard, France, 25200
    - Pfizer Investigational Site
  - Monteux, France, 84170
    - Pfizer Investigational Site
  - Montpellier, France, 34000
    - Pfizer Investigational Site
  - Montpellier, France, 34070
    - Pfizer Investigational Site
  - Montreuil, France, 93100
    - Pfizer Investigational Site
  - Montrevel En Bresse, France, 01340
    - Pfizer Investigational Site
  - Moreuil, France, 80110
    - Pfizer Investigational Site
  - Morlaix, France, 29600
    - Pfizer Investigational Site
  - Mourenx, France, 64150
    - Pfizer Investigational Site
  - Muespach, France, 68640
    - Pfizer Investigational Site
  - Mulhouse, France, 68100
    - Pfizer Investigational Site
  - Mulhouse, France, 68200
    - Pfizer Investigational Site
  - Mundolsheim, France, 67450
    - Pfizer Investigational Site
  - Nancy, France, 54000
    - Pfizer Investigational Site
  - Nantes, France, 44000
    - Pfizer Investigational Site
  - Nantes, France, 44100
    - Pfizer Investigational Site
  - Nantes, France, 44200
    - Pfizer Investigational Site
  - Neris Les Bains, France, 03310
    - Pfizer Investigational Site
  - Nevers, France, 58000
    - Pfizer Investigational Site
  - Nice, France, 06000
    - Pfizer Investigational Site
  - Nice, France, 06300
    - Pfizer Investigational Site
  - Nice, France, 06200
    - Pfizer Investigational Site
  - Nice, France, 06 000
    - Pfizer Investigational Site
  - Niort, France, 79000
    - Pfizer Investigational Site
  - Nogent Sur Marne, France, 94130
    - Pfizer Investigational Site
  - Noisiel, France, 77186
    - Pfizer Investigational Site
  - Noyon, France, 60400
    - Pfizer Investigational Site
  - Oberhausbergen, France, 67205
    - Pfizer Investigational Site
  - Obernai, France, 67210
    - Pfizer Investigational Site
  - Objat, France, 19130
    - Pfizer Investigational Site
  - Orange, France, 84100
    - Pfizer Investigational Site
  - Orchamps, France, 39700
    - Pfizer Investigational Site
  - Orry La Ville, France, 60560
    - Pfizer Investigational Site
  - Osses, France, 64780
    - Pfizer Investigational Site
  - Pacy Sur Eure, France, 27210
    - Pfizer Investigational Site
  - Palau Del Vidre, France, 66690
    - Pfizer Investigational Site
  - Paris, France, 75015
    - Pfizer Investigational Site
  - Paris, France, 75019
    - Pfizer Investigational Site
  - Paris, France, 75020
    - Pfizer Investigational Site
  - Paris, France, 75018
    - Pfizer Investigational Site
  - Paris, France, 75013
    - Pfizer Investigational Site
  - Paris, France, 75014
    - Pfizer Investigational Site
  - Paris, France, 75012
    - Pfizer Investigational Site
  - Paris, France, 75017
    - Pfizer Investigational Site
  - Paris, France, 75009
    - Pfizer Investigational Site
  - Paris, France, 75116
    - Pfizer Investigational Site
  - Parthenay, France, 79200
    - Pfizer Investigational Site
  - Perpignan, France, 66100
    - Pfizer Investigational Site
  - Pessac, France, 33600
    - Pfizer Investigational Site
  - Petit Couronne, France, 76650
    - Pfizer Investigational Site
  - Pfulgriesheim, France, 67370
    - Pfizer Investigational Site
  - Phalempin, France, 59133
    - Pfizer Investigational Site
  - Pont A Mousson, France, 54700
    - Pfizer Investigational Site
  - Portet Sur Garonne, France, 31120
    - Pfizer Investigational Site
  - Porto Vecchio, France, 20137
    - Pfizer Investigational Site
  - Poussan, France, 34560
    - Pfizer Investigational Site
  - Pradines, France, 46090
    - Pfizer Investigational Site
  - Precy Sur Oise, France, 60460
    - Pfizer Investigational Site
  - Quimperle, France, 29300
    - Pfizer Investigational Site
  - Rebais, France, 77510
    - Pfizer Investigational Site
  - Reims, France, 51100
    - Pfizer Investigational Site
  - Remiremont, France, 88200
    - Pfizer Investigational Site
  - Rennes, France, 35200
    - Pfizer Investigational Site
  - Rigney, France, 25640
    - Pfizer Investigational Site
  - Rodez Cedex, France, 12001
    - Pfizer Investigational Site
  - Rognac, France, 13340
    - Pfizer Investigational Site
  - Rohrwiller, France, 67410
    - Pfizer Investigational Site
  - Romans Sur Isere, France, 26100
    - Pfizer Investigational Site
  - Roncq, France, 59223
    - Pfizer Investigational Site
  - Roquevaire, France, 13360
    - Pfizer Investigational Site
  - Roubaix, France, 59100
    - Pfizer Investigational Site
  - Roubaix Cedex 1, France, 59071
    - Pfizer Investigational Site
  - Rozay En Brie, France, 77540
    - Pfizer Investigational Site
  - Saint Martin D'Oney, France, 40090
    - Pfizer Investigational Site
  - Saint-etienne, France, 42000
    - Pfizer Investigational Site
  - Salles, France, 33770
    - Pfizer Investigational Site
  - Salon De Provence, France, 13300
    - Pfizer Investigational Site
  - Sanary Sur Mer, France, 83110
    - Pfizer Investigational Site
  - Sarlat La Caneda, France, 24200
    - Pfizer Investigational Site
  - Sartrouville, France, 78500
    - Pfizer Investigational Site
  - Schweighouse Sur Moder, France, 67590
    - Pfizer Investigational Site
  - Selestat, France, 67600
    - Pfizer Investigational Site
  - Semur En Auxois, France, 21140
    - Pfizer Investigational Site
  - Sete, France, 34200
    - Pfizer Investigational Site
  - Sevrier, France, 74320
    - Pfizer Investigational Site
  - Soissons, France, 02200
    - Pfizer Investigational Site
  - Solgne, France, 57420
    - Pfizer Investigational Site
  - St. Agreve, France, 07320
    - Pfizer Investigational Site
  - St. Avold, France, 57500
    - Pfizer Investigational Site
  - St. Brieuc Cedex 1, France, 22015
    - Pfizer Investigational Site
  - St. Denis, France, 93200
    - Pfizer Investigational Site
  - St. Die Des Vosges, France, 88100
    - Pfizer Investigational Site
  - St. Erme Outre Et Ramecourt, France, 02820
    - Pfizer Investigational Site
  - St. Etienne, France, 42100
    - Pfizer Investigational Site
  - St. Fons, France, 69190
    - Pfizer Investigational Site
  - St. Germain Au Mont D'Or, France, 69650
    - Pfizer Investigational Site
  - St. Germain De Marencennes, France, 17700
    - Pfizer Investigational Site
  - St. Girons, France, 09200
    - Pfizer Investigational Site
  - St. Jean De Braye, France, 45800
    - Pfizer Investigational Site
  - St. Jean De Luz, France, 64500
    - Pfizer Investigational Site
  - St. Jean De Maurienne, France, 73300
    - Pfizer Investigational Site
  - St. Joachim, France, 44720
    - Pfizer Investigational Site
  - St. Leu D'Esserent, France, 60340
    - Pfizer Investigational Site
  - St. Leu La Foret, France, 95320
    - Pfizer Investigational Site
  - St. Marcel Les Valence, France, 26320
    - Pfizer Investigational Site
  - St. Martin D'Heres, France, 38400
    - Pfizer Investigational Site
  - St. Martin Des Champs, France, 50300
    - Pfizer Investigational Site
  - St. Martin Du Bois, France, 49500
    - Pfizer Investigational Site
  - St. Morillon, France, 33650
    - Pfizer Investigational Site
  - St. Ouen, France, 93400
    - Pfizer Investigational Site
  - St. Ouen L'Aumone, France, 95310
    - Pfizer Investigational Site
  - St. Rambert D'Albon, France, 26140
    - Pfizer Investigational Site
  - St. Raphael, France, 83700
    - Pfizer Investigational Site
  - St. Remy De Provence, France, 13210
    - Pfizer Investigational Site
  - St. Saulve, France, 59880
    - Pfizer Investigational Site
  - St. Sebastien Sur Loire, France, 44230
    - Pfizer Investigational Site
  - St. Sulpice, France, 81370
    - Pfizer Investigational Site
  - St. Tropez, France, 83990
    - Pfizer Investigational Site
  - St. Yrieix La Perche, France, 87500
    - Pfizer Investigational Site
  - Ste. Maxime, France, 83120
    - Pfizer Investigational Site
  - Ste. Suzanne, France, 53270
    - Pfizer Investigational Site
  - Strasbourg, France, 67000
    - Pfizer Investigational Site
  - Strasbourg, France, 67200
    - Pfizer Investigational Site
  - Suresnes, France, 92150
    - Pfizer Investigational Site
  - Targon, France, 33760
    - Pfizer Investigational Site
  - Tergnier, France, 02700
    - Pfizer Investigational Site
  - Thiant, France, 59224
    - Pfizer Investigational Site
  - Thierville Sur Meuse, France, 55840
    - Pfizer Investigational Site
  - Thiviers, France, 24800
    - Pfizer Investigational Site
  - Thones, France, 74230
    - Pfizer Investigational Site
  - Toul, France, 54200
    - Pfizer Investigational Site
  - Toulon, France, 83000
    - Pfizer Investigational Site
  - Toulon, France, 83200
    - Pfizer Investigational Site
  - Toulouse, France, 31400
    - Pfizer Investigational Site
  - Toulouse, France, 31000
    - Pfizer Investigational Site
  - Toulouse, France, 31200
    - Pfizer Investigational Site
  - Toulouse, France, 31500
    - Pfizer Investigational Site
  - Toulouse, France, 31100
    - Pfizer Investigational Site
  - Tours, France, 37000
    - Pfizer Investigational Site
  - Trie Sur Baise, France, 65220
    - Pfizer Investigational Site
  - Vabres L'Abbaye, France, 12400
    - Pfizer Investigational Site
  - Vacqueyras, France, 84190
    - Pfizer Investigational Site
  - Vagney, France, 88120
    - Pfizer Investigational Site
  - Valenciennes, France, 59300
    - Pfizer Investigational Site
  - Valognes, France, 50700
    - Pfizer Investigational Site
  - Valreas, France, 84600
    - Pfizer Investigational Site
  - Vals Les Bains, France, 07600
    - Pfizer Investigational Site
  - Vandoeuvre Les Nancy, France, 54500
    - Pfizer Investigational Site
  - Vannes, France, 56000
    - Pfizer Investigational Site
  - Varces Allieres Et Risset, France, 38760
    - Pfizer Investigational Site
  - Vatan, France, 36150
    - Pfizer Investigational Site
  - Velines, France, 24230
    - Pfizer Investigational Site
  - Velizy Villacoublay, France, 78140
    - Pfizer Investigational Site
  - Vence, France, 06140
    - Pfizer Investigational Site
  - Venissieux, France, 69200
    - Pfizer Investigational Site
  - Vernet, France, 31810
    - Pfizer Investigational Site
  - Viane, France, 81530
    - Pfizer Investigational Site
  - Villard Bonnot, France, 38190
    - Pfizer Investigational Site
  - Villefranche Sur Mer, France, 06230
    - Pfizer Investigational Site
  - Villefranche Sur Saone, France, 69400
    - Pfizer Investigational Site
  - Villefranche de Rouergue, France, 12200
    - Pfizer Investigational Site
  - Villeneuve Les Maguelone, France, 34750
    - Pfizer Investigational Site
  - Villeparisis, France, 77270
    - Pfizer Investigational Site
  - Villers St. Paul, France, 60870
    - Pfizer Investigational Site
  - Villette D'Anthon, France, 38280
    - Pfizer Investigational Site
  - Viry Chatillon, France, 91170
    - Pfizer Investigational Site
  - Vitrolles, France, 13127
    - Pfizer Investigational Site
  - Vix, France, 85770
    - Pfizer Investigational Site
  - Wambrechies, France, 59118
    - Pfizer Investigational Site
  - Wasselonne, France, 67310
    - Pfizer Investigational Site
  - Wattignies, France, 59139
    - Pfizer Investigational Site
  - Wattrelos, France, 59150
    - Pfizer Investigational Site
  - Witry Les Reims, France, 51420
    - Pfizer Investigational Site
  - Yffiniac, France, 22120
    - Pfizer Investigational Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

All

Description

Inclusion Criteria:

1.Male or female, 18 years of age or over, 2.Patient with hypertension and at least three other CV risk factors, 3.Hypertension, treated or not, but not at the currently recommended goals (140/90 mmHg for most patients, 130/80 mmHg for patients with diabetes or nephropathy). In case of treated hypertension, patients should be on their current treatment for at least 4 weeks before randomisation,

Exclusion Criteria:

1. Patient with a history of coronary heart disease, 2.Patients with a history of familial hypercholesterolemia, 3.Patient with malignant HTN, 4.Non-essential hypertension, 5.Known hypersensitivity to dihydropyridines, 6.Patients already receiving a dihydropyridine, 7.Known hypersensitivity to HMG-CoA-reductase inhibitors, 8.Patients currently receiving or who has received a HMG-CoA-reductase within the 3 months prior to selection, 9.Patients currently receiving or who has received a fibric acid, resins, ezetimibe, nicotinic acid and all other drug which is known to affect lipid levels, within 6 weeks prior to selection,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Interventional Model: Parallel Assignment
Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
% reduction in Framingham's predicted 10-year risk of a coronary event between V1 and V3 in the Caduet group compared to the usual care group (6) (including diabetic patients)

Secondary Outcome Measures

Outcome Measure
1. % patients changing risk category between V1 and V3 2. % reduction in Framingham's predicted 10-year risk of a coronary event (8) excluding diabetic patients 3. Clinical and biological safety during treatment period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

To obtain contact information for a study center near you, click here.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2006

Study Completion (Actual)

April 1, 2007

Study Registration Dates

First Submitted

February 27, 2006

First Submitted That Met QC Criteria

February 27, 2006

First Posted (Estimate)

March 1, 2006

Study Record Updates

Last Update Posted (Actual)

January 27, 2021

Last Update Submitted That Met QC Criteria

January 26, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

A3841038

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

National Taiwan University Hospital Hsin-Chu Branch

Recruiting

Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.

Hypertension,Essential | Hypertension, Masked

Taiwan
University of Alabama at Birmingham
Troy University

Completed

Use of Automated Office Blood Pressure Monitoring

Hypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White Coat

United States
Bayer

Completed

Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)

Primary Hypertension

China
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-209

Hypertension, Essential

Korea, Republic of
Bayer

Completed

Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions

Hypertension, Essential

Germany
Columbia University
Agency for Healthcare Research and Quality (AHRQ)

Active, not recruiting

Implementing Hypertension Screening Guidelines in Primary Care

White Coat Hypertension | Hypertension,Essential

United States
Universidade Federal de Santa Maria

Completed

Effects of TENS and IES on the Autonomous Balance of Normotens Volunteers and Hypertensive Patients

Healthy Volunteers | Hypertension, Essential

Brazil
Cytos Biotechnology AG

Completed

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Mild Essential Hypertension | Moderate Essential Hypertension

Switzerland
Sulaiman AlRajhi Colleges

Unknown

The Association Between Serum β-hydroxybutyrate and Levels of Systemic Hypertension (BHB-RCT)

Hypertension, Essential | β-hydroxybutyrate
Centre Chirurgical Marie Lannelongue

Unknown

Determinants of Right Heart Remodeling in Patients With CTEPH or PAH (PRINCEPT)

Chronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial Hypertension

France

Clinical Trials on Blood samples

Assistance Publique Hopitaux De Marseille

Completed

Effect of Intake in Bioactive Molecules From Natural or Pasteurised Milk on Gut Maturation in Very Premature Newborns

Premature Birth

France
Centre Hospitalier Universitaire Dijon

Completed

Study of Immune Thrombocytopenia Pathogenesis: (PTI PARI)

Primary Immune Thrombocytopenia (ITP)

France
Institut Bergonié

Unknown

STUDY OF THE EXPRESSION OF CIRCULATING AND INTRA-TUMORAL CHEMOKINES IN PATIENTS WITH PROSTATE CANCER (CHEMOPROST)

Prostate Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank (BIO-F)

Paediatric Malignancies

France
Centre Georges Francois Leclerc

Completed

Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for the Monitoring and Early Diagnosis of Malignant Solid Tumors (EXODIAG)

Cancer

France
Centre Hospitalier Universitaire de Nīmes

Completed

Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura (FOX-TREG)

Henoch Schönlein Purpura

France
Centre Hospitalier Universitaire Dijon

Completed

Medico-economic Evaluation of Different High-throughput Sequencing Strategies in the Diagnosis of Patients With Intellectual Deficiency (DISSEQ)

Intellectual Deficiency

France
Assistance Publique Hopitaux De Marseille

Recruiting

A DERMO-EPIDERMAL AUTOLOGOUS SKIN SUBSTITUTE FOR FURTHER THERAPEUTIC USE (BIOPSKIN)

Plastic Surgeries

France
University Hospital, Bordeaux

Recruiting

Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre (SCLERESO)

Systemic Sclerosis | Scleroderma

France
Centre Hospitalier Universitaire, Amiens

Completed

Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma (MCSF-MYELOME)

Multiple Myeloma

France

Cardiovascular Risk Assessment in Patients Treated With Caduet (RIGHT)

Cardiovascular Risk Assessment In Patients With Hypertension And At Least Three Other Risk Factors, Treated With Caduet Compared To Usual Care: The Right Study

Study Overview

Status

Conditions

Intervention / Treatment

Study Type

Enrollment (Actual)

Phase

Contacts and Locations

Study Locations

Participation Criteria

Eligibility Criteria

Ages Eligible for Study

Accepts Healthy Volunteers

Genders Eligible for Study

Description

Study Plan

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure

Secondary Outcome Measures

Outcome Measure

Collaborators and Investigators

Sponsor

Publications and helpful links

Helpful Links

Study record dates

Study Major Dates

Study Start

Study Completion (Actual)

Study Registration Dates

First Submitted

First Submitted That Met QC Criteria

First Posted (Estimate)

Study Record Updates

Last Update Posted (Actual)

Last Update Submitted That Met QC Criteria

Last Verified

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Clinical Trials on Hypertension

Clinical Trials on Blood samples

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations